MAXILASE

Pancrelipase, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases.

These enzymes are extracted from porcine pancreatic glands.

The amylases are enzymes that help in the chemical process of digestion by hydrolizing starch into more available saccharide forms.

The pancrelipase amylase is a single polypeptide chain containing two SH groups and four disulfide bridges.

The pancrelipase mixture, including pancrelipase amylase, was developed by Ortho-McNeil-Janssen Pharmaceuticals, Inc and FDA approved on April 12, 2010.

Please refer to

Please refer to

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.

Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR).

Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Before, during and/or after pregnancy, one softgel daily or as directed by a physician.

is supplied in child-resistant bottles of 30 softgels (NDC# 42192-321-30).

Store at 20°.

• 25°C (68° - 77°F); excursions permitted to 15°.

• 30°C (59° - 86°F).